News
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...
It's a new day for weight loss treatment, with anti-obesity medications coming on the market that appear safe, at least in the short-term. Two medications in this class, Ozempic and Mounjaro, are ...
This can result in weight loss but experts point out that Ozempic has not been approved for that purpose, though semaglutide at a higher dose (Wegovy) has been. Wegovy is the first drug since 2014 ...
How Ozempic, other weight-loss drugs are "changing medicine" 08:40. Forty-four-year-old LaQuita Clark says memories of being overweight – and ridiculed – go back to middle school.
Diabetes medication Ozempic has become part of the weight-loss craze on social media and among celebrities as well. Fox News medical contributor Dr. Marc Siegel explained what's going on.
As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side effect: family members who are not taking the drugs are changing their ...
Dozens of lawsuits allege drugmakers failed to notify patients about side effects of popular diabetes or weight loss drugs such as Ozempic, Wegovy and Mounjaro.
The introduction of weight loss drugs like Wegovy and Ozempic marked significant advancements in treating obesity, yet health experts recently cautioned that their misuse could result in eating ...
Health Ozempic, other semaglutides linked to hair loss: Here's what to know Study participants were 50% more likely to have hair loss with the diabetes and weight-loss drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results